A detailed history of Folger Nolan Fleming Douglas Capital Management, Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Folger Nolan Fleming Douglas Capital Management, Inc holds 105,789 shares of JNJ stock, worth $16.4 Million. This represents 1.87% of its overall portfolio holdings.

Number of Shares
105,789
Previous 107,195 1.31%
Holding current value
$16.4 Million
Previous $15.7 Million 9.43%
% of portfolio
1.87%
Previous 1.76%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$145.48 - $167.38 $204,544 - $235,336
-1,406 Reduced 1.31%
105,789 $17.1 Million
Q2 2024

Jul 09, 2024

BUY
$144.38 - $157.78 $50,099 - $54,749
347 Added 0.32%
107,195 $15.7 Million
Q1 2024

Apr 12, 2024

BUY
$155.22 - $162.74 $18,936 - $19,854
122 Added 0.11%
106,848 $16.9 Million
Q4 2023

Feb 05, 2024

SELL
$145.6 - $158.88 $205,878 - $224,656
-1,414 Reduced 1.31%
106,726 $16.7 Million
Q3 2023

Oct 25, 2023

SELL
$155.75 - $174.48 $105,287 - $117,948
-676 Reduced 0.62%
108,140 $16.8 Million
Q2 2023

Jul 27, 2023

BUY
$154.35 - $166.11 $225,042 - $242,188
1,458 Added 1.36%
108,816 $18 Million
Q1 2023

Apr 28, 2023

SELL
$151.05 - $180.26 $210,110 - $250,741
-1,391 Reduced 1.28%
107,358 $16.6 Million
Q4 2022

Jan 30, 2023

BUY
$160.2 - $179.79 $206,337 - $231,569
1,288 Added 1.2%
108,749 $19.2 Million
Q3 2022

Nov 01, 2022

BUY
$161.33 - $179.52 $148,907 - $165,696
923 Added 0.87%
107,461 $17.6 Million
Q2 2022

Jul 15, 2022

SELL
$168.19 - $186.01 $91,495 - $101,189
-544 Reduced 0.51%
106,538 $18.9 Million
Q1 2022

Apr 27, 2022

BUY
$158.14 - $179.59 $13,441 - $15,265
85 Added 0.08%
107,082 $19 Million
Q4 2021

Feb 01, 2022

BUY
$155.93 - $173.01 $111,801 - $124,048
717 Added 0.67%
106,997 $18.3 Million
Q3 2021

Oct 29, 2021

BUY
$161.5 - $179.47 $290,215 - $322,507
1,797 Added 1.72%
106,280 $17.2 Million
Q2 2021

Aug 09, 2021

SELL
$159.48 - $171.07 $208,121 - $223,246
-1,305 Reduced 1.23%
104,483 $17.2 Million
Q1 2021

May 11, 2021

BUY
$153.07 - $170.48 $119,547 - $133,144
781 Added 0.74%
105,788 $17.4 Million
Q4 2020

Feb 05, 2021

SELL
$137.11 - $157.38 $130,665 - $149,983
-953 Reduced 0.9%
105,007 $16.5 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $114,128 - $125,063
813 Added 0.77%
105,960 $15.8 Million
Q2 2020

Aug 05, 2020

SELL
$128.81 - $155.51 $79,604 - $96,105
-618 Reduced 0.58%
105,147 $14.8 Million
Q1 2020

May 06, 2020

SELL
$111.14 - $153.99 $202,385 - $280,415
-1,821 Reduced 1.69%
105,765 $13.9 Million
Q4 2019

Feb 12, 2020

SELL
$127.5 - $146.44 $168,555 - $193,593
-1,322 Reduced 1.21%
107,586 $15.7 Million
Q3 2019

Nov 08, 2019

SELL
$126.95 - $142.14 $552,105 - $618,166
-4,349 Reduced 3.84%
108,908 $14.1 Million
Q2 2019

Aug 09, 2019

SELL
$131.15 - $144.24 $64,525 - $70,966
-492 Reduced 0.43%
113,257 $15.8 Million
Q1 2019

May 07, 2019

SELL
$125.72 - $139.79 $87,752 - $97,573
-698 Reduced 0.61%
113,749 $15.9 Million
Q4 2018

Feb 12, 2019

BUY
$122.84 - $147.84 $12.2 Million - $14.7 Million
99,678 Added 674.91%
114,447 $14.8 Million
Q4 2018

Feb 11, 2019

SELL
$122.84 - $147.84 $12.2 Million - $14.7 Million
-99,273 Reduced 87.05%
14,769 $14.8 Million
Q3 2018

Nov 07, 2018

SELL
$121.58 - $142.88 $143,099 - $168,169
-1,177 Reduced 1.02%
114,042 $15.8 Million
Q2 2018

Aug 08, 2018

BUY
$119.4 - $131.76 $597 - $658
5 Added 0.0%
115,219 $14 Million
Q1 2018

May 07, 2018

SELL
$125.1 - $148.14 $271,467 - $321,463
-2,170 Reduced 1.85%
115,214 $14.8 Million
Q4 2017

Feb 12, 2018

SELL
$131.22 - $143.62 $551,648 - $603,778
-4,204 Reduced 3.46%
117,384 $16.4 Million
Q3 2017

Nov 09, 2017

SELL
$129.47 - $135.38 $165,203 - $172,744
-1,276 Reduced 1.04%
121,588 $15.8 Million
Q2 2017

Aug 11, 2017

BUY
N/A
122,864
122,864 $16.3 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Folger Nolan Fleming Douglas Capital Management, Inc Portfolio

Follow Folger Nolan Fleming Douglas Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Folger Nolan Fleming Douglas Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Folger Nolan Fleming Douglas Capital Management, Inc with notifications on news.